Immunocompromised clinical trials at UCSD

• Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

  open to all eligible people

  This study will seek to enroll immunocompromised patients with Lower Tract parainfluenza infection. It also contains a sub-study to enroll patients with severe COVID-19.

  San Diego, California and other locations

Last updated: February 17, 2021